US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: Eyeing a 74.90% Potential Upside with Robust Analyst Ratings

ADMA Biologics Inc (NASDAQ: ADMA), a notable player in the biotechnology sector, is drawing investor attention with its promising stock potential and analyst confidence. Specializing in..

Regencell Bioscience Holdings L (RGC): Investor Outlook on Market Dynamics and Growth Challenges

Regencell Bioscience Holdings L (RGC), a Hong Kong-based company, is carving out a niche in the healthcare sector by leveraging Traditional Chinese Medicine (TCM) to target..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Steady Path in the Biotech Sector

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology industry, is garnering attention from investors seeking stability in the healthcare sector. With a market capitalization..

BridgeBio Pharma, Inc. (BBIO): Potential 62.22% Upside Amid Robust Revenue Growth and Analyst Confidence

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing the attention of investors with its significant potential upside of 62.22%, according to analyst ratings. This Palo Alto-based biotechnology..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Reveals 87% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning player in the biotechnology sector, offers a promising investment opportunity with significant upside potential. This Australian-based biopharmaceutical company specializes..

Ascendis Pharma A/S (ASND): Investor Outlook Reveals 34% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical company, is capturing investor attention with its impressive growth metrics and promising analyst ratings. Positioned within the dynamic..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth and Market Sentiments with a $9.64 Billion Valuation

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector with a focus on medical devices, has caught the attention of investors with its robust..

Axsome Therapeutics (AXSM) Stock Analysis: A 58.79% Upside Potential in CNS Disorder Treatments

Axsome Therapeutics, Inc. (AXSM), a trailblazer in the biopharmaceutical realm, is making waves with its promising portfolio targeting central nervous system (CNS) disorders. Headquartered in New..

Johnson & Johnson (JNJ) Stock Analysis: Investor Outlook on a Healthcare Giant with a Potential 9% Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to attract investor attention with its solid market position and promising growth prospects. As..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 36.59% Potential Upside in the Biotech Sector

Individual investors looking for opportunities in the healthcare sector might find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing proposition. With a market capitalization of $11.54 billion,..

West Pharmaceutical Services (WST): Analyst Consensus Points to 11.67% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector specializing in medical instruments and supplies, has captured the attention of investors with..

Waystar Holding Corp. (WAY) Stock Analysis: Unpacking a 35.76% Upside Potential in Healthcare Tech

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, presents an intriguing investment opportunity with a potential upside of 35.76%. The company,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Understanding the 18.84% Potential Upside

Investors eyeing the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing proposition. With a market capitalization of $5.1 billion, this Utah-based company..

Guardant Health, Inc. (GH) Stock Analysis: A 11% Potential Upside Amid Robust Revenue Growth

Guardant Health, Inc. (GH), a leader in precision oncology, is capturing investor interest with its impressive revenue growth and a potential upside of 11.05%. With a..

Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 49.8% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, is capturing investor attention with its robust product portfolio and promising market position...

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Revolution with a 9.40% Revenue Growth

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry with its cutting-edge genomic analysis solutions...

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a Promising 60% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, is capturing investor attention with a compelling potential upside of 60.22%, according to the latest..

Incyte Corporation (INCY): Investor Outlook with 11.8% Potential Upside Reveals Promising Growth in Biotech

In the ever-evolving landscape of biotechnology, Incyte Corporation (NASDAQ: INCY) stands out as a formidable player. Headquartered in Wilmington, Delaware, this biopharmaceutical powerhouse engages in the..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -36.49% Potential Downside Amidst Global Vaccine Innovation

As Moderna, Inc. (NASDAQ: MRNA) continues to make headlines with its groundbreaking work in messenger RNA (mRNA) medicines, investors are closely watching the company’s financial health..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring Growth Potential with a 4.42% Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry, presents an intriguing investment opportunity. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds